Management of patients with chronic hepatitis B

Journal of Gastroenterology and Hepatology (Australia)

Volumn 17, Issue 4, 2002, Pages 406-408

  Liaw, Yun Fan ^a,b  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Chronic hepatitis; Chronic hepatitis B virus infection; Cirrhosis; Consensus management; Corticosteroid priming; Covalently closed circular DNA; Hepatic decompensation; Hepatitis flares; Hepatocellular carcinoma; Lamivudine; interferon

Indexed keywords

ADEFOVIR DIPIVOXIL; ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; CLEVUDINE; EMTRICITABINE; ENTECAVIR; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; NUCLEOSIDE ANALOG; NUCLEOTIDE DERIVATIVE; THYMOSIN ALPHA1; VIRUS DNA;

ANTIVIRAL ACTIVITY; CLINICAL TRIAL; CONFERENCE PAPER; DISEASE COURSE; DRUG EFFICACY; DRUG MECHANISM; DRUG TOLERABILITY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CELL; LIVER CIRRHOSIS; META ANALYSIS; MUTATION; PATHOGENESIS; PRIORITY JOURNAL; SEROCONVERSION; VIRUS REPLICATION;

EID: 0036096740     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2002.02736.x     Document Type: Conference Paper

References (10)

1. Pathogenesis and clinical significance of acute exacerbations and remissions in patients with chronic hepatitis B virus infection
2. Consensus statements on the prevention and management of hepatitis B and C in the Asia-Pacific region
3. Present and future directions in the treatment of chronic hepatitis B infection
4. Current trends in therapy for chronic viral hepatitis
5. The development of cirrhosis in patients with chronic type B hepatitis: A prospective study
6. Interferon monotherapy in chronic hepatitis B
7. Treatment of chronic hepatitis B virus infection in special groups of patients: Decompensated cirrhosis, immunosuppressed and paediatric patients
8. Use of immunomodulatory therapy (other than interferon) for the treatment of chronic hepatitis B virus infection
9. Nucleoside analogues in the treatment of chronic hepatitis B
10. Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy